Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Elisabeth Gödde"'
Autor:
Stefan Luppold, Tobias Hönig, Elisabeth Gödde, Klaus Riedel, Isabell Maurer, Patrick Haag, Lisa Ruetz
Messeveranstalter stehen sehr unterschiedlichen Anspruchsgruppen gegenüber. Der richtige Umgang mit ihnen ist dabei ein wesentlicher Erfolgsfaktor. Heterogenität und Wandel verhindern ein statisches Verhalten - weshalb immer wieder neue Ansätze im
Autor:
Elisabeth Gödde
Publikováno v:
Erfahrungsheilkunde. 59:189-198
A hereditary disposition can be present for different cancer diseases. The people affected have an increased risk, to fall ill with a certain kind of cancer. The author explains which genes are affected, which methods for a gene analysis are availabl
Autor:
Elisabeth Gödde
Publikováno v:
Deutsche Zeitschrift für Onkologie. 32:72-77
Autor:
Elisabeth Gödde
Publikováno v:
Medizinische Klinik. 94:25-28
□Hintergrund: Krebserkrankungen sind dadurch gekennzeichnet, das nach abgeschlossener Primarbehandlung und (zumindest mit den ublichen diagnostischen Verfahren) nicht mehr nachweisbaren Tumorzellen das Risiko besteht, das nach einiger Zeit in ander
Autor:
Werner Grote, Elisabeth Gödde, A. C. Feller, Annekathrin Himmler, Karl Lennert, Brigitte Schlegelberger
Publikováno v:
Blood. 83:505-511
Cytogenetic studies on lymph node and skin biopsy specimens and peripheral blood in 104 patients with peripheral T-cell lymphomas (PTL) were compared with histopathologic diagnoses made according to the updated Kiel classification. Low-grade lymphoma
Autor:
A Polityko, Anja Weise, Marina Manvelyan, Dilek Aktas, Hans-Christoph Duba, Thomas Liehr, Franck Pellestor, Daniela Reich, Peter Küpferling, Bernt Schulze, Hanne Tittelbach, Ute Hehr, Marie-Luise Mazaurik, Elisabeth Gödde, Mònica Santos, Thomas Martin, Isolde Schreyer, Sigrid Köhler, Marianne Volleth, Gisela Reising-Ackermann, Carme Fuster, Britta Belitz, Elisabeth Ewers, Jasen Anderson, Andreas Dufke, Mariluce Riegel, Kristin Mrasek, Christina Kelbova
Publikováno v:
ResearcherID
Thirty-two patients with fertility problems were identified as carriers of small supernumerary marker chromosomes (sSMC). Molecular cytogenetic techniques were used to characterize their chromosomal origin. Together with the other cases available in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b5f6d2769c959ecfadc2a02ae28a0f
https://doi.org/10.5167/uzh-57505
https://doi.org/10.5167/uzh-57505
Publikováno v:
Cancer Genetics and Cytogenetics. 50:15-29
Cytogenetic studies of lymphoproliferative diseases, such as angioimmunoblastic lymphadenopathy (AILD), may provide a clue to the understanding of tumor development. Angioimmunoblastic lymphadenopathy may evolve from a nonmalignant lymphoproliferatio
Autor:
Elisabeth Gödde-Salz
Publikováno v:
Cancer Genetics and Cytogenetics. 20:293-299
Engraftment after bone marrow transplantation (BMT) can be monitored with genetic markers. Cytogenetic markers are the ones that can be studied earliest. Of 27 patients studied, 16 had a sex-mismatched donor, and in 8 cases, there were discriminative
Chromosomal abnormalities in lymphogranulomatosis X (LgrX)/angioimmunoblastic lymphadenopathy (AILD)
Publikováno v:
Leukemia Research. 11:181-190
Histologically, lymphogranulomatosis X (LgrX) is a Morbus Hodgkin-like disease which until now has been considered as an abnormal immune reaction or a prelymphoma. Chromosome analyses showed that LgrX and angioimmunoblastic lymphadenopathy (AILD) are
Autor:
Elisabeth Gödde, Eyna von Zelewski
Publikováno v:
Cancer Genetics and Cytogenetics. 2:7-11
A case of Ph1-positive chronic myelocytic leukemia with temporary loss of the Y chromosome is described. Loss of the Y chromosome in relation to clinical course and therapy is discussed.